HIV infection and bone loss due to periodontal disease

Journal of Periodontology

Volumn 81, Issue 6, 2010, Pages 877-884

  Aichelmann Reidy, Mary E ^a   Wrigley, Dena L ^b   Gunsolley, John C ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b Private Practice   (Canada)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Alveolar bone loss; HIV; Periodontitis; Risk factor; Smoking; Substance related disorders

Indexed keywords

EID: 77953236596     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.070675     Document Type: Article

References (36)

1. Kroidl A, Schaeben A, Oette M, Wettstein M, Herfordt A, Häussinger D. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy. Eur J Med Res 2005;10:448-453.
2. Baqui A, Meiller T, Jabra-Rizk M, Zhang M, Kelley J, Falkler W. Association of HIV viral load with oral diseases. Oral Dis 1999;5:294-298.
3. McKaig RG, Thomas JC, Patton LL, Strauss RP, Slade GD, Beck JD. Prevalence of HIV-associated periodontitis and chronic periodontitis in a southeastern US study group. J Public Health Dent 1998;58:294-300.
4. Martínez-Canut P, Guarinos J, Bagán JV. Periodontal disease in HIV seropositive patients and its relation to lymphocyte subsets. J Periodontol 1996;67:33-36.
5. Klein RS, Quart AM, Small CB. Periodontal disease in heterosexuals with acquired immunodeficiency syndrome. J Periodontol 1991;62:535-540.
6. Pinheiro A, Marcenes W, Zakrzewska JM, Robinson PG. Dental and oral lesions in HIV infected patients: A study in Brazil. Int Dent J 2004;54:131-137.
7. Arendorf TM, Bredekamp B, Cloete CA, Sauer G. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 1998;27:176-179.
8. Tomar SL, Swango PA, Kleinman DV, Burt BA. Loss of periodontal attachment in HIV-seropositive military personnel. J Periodontol 1995;66:421-428.
9. Friedman RB, Gunsolley J, Gentry A, Dinius A, Kaplowitz L, Settle J. Periodontal status of HIV-seropositive and AIDS patients. J Periodontol 1991;62:623-627.
10. Ndiaye CF, Critchlow CW, Leggott PJ, et al. Periodontal status of HIV-1 and HIV-2 seropositive and HIV seronegative female commercial sex workers in Senegal. J Periodontol 1997;68:827-831.
11. Robinson PG, SheihamA, Challacombe SJ, Zakrzewska JM. The periodontal health of homosexual men with HIV infection: A controlled study. Oral Dis 1996;2:45-52.
12. Goncxalves Lde S, Soares Ferreira SM, Souza CO, Souto R, Colombo AP. Clinical and microbiological profiles of human immunodeficiency virus (HIV)-seropositive Brazilians undergoing highly active antiretroviral therapy and HIV-seronegative Brazilians with chronic periodontitis. J Periodontol 2007;78:87-96.
13. Smith GL, Cross DL, Wray D. Comparison of periodontal disease in HIV seropositive subjects and controls (I). Clinical features. J Clin Periodontol 1995;22:558-568.
14. Scheutz F, Matee MI, Andsager L, et al. Is there an association between periodontal condition and HIV infection? J Clin Periodontol 1997;24:580-587.
15. Alpagot T, Font K, Lee A. Longitudinal evaluation of GCF IFN-gamma levels and periodontal status in HIV+ patients. J Clin Periodontol 2003;30:944-948.
16. Alpagot T, Duzgunesx N, Wolff LF, Lee A. Risk factors for periodontitis in HIV patients. J Periodontal Res 2004;39:149-157.
17. Alpagot T, Suzara V, Bhattacharyya M. The associations between gingival crevice fluid matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and periodontitis in human immunodeficiency viruspositive patients. J Periodontal Res 2006;41:491-497.
18. 2) and periodontal status in HIV+ patients. Arch Oral Biol 2007;52:1102-1108.
19. Alpagot T, Konopka K, Bhattacharyya M, Gebremedhin S, Duzgunesx N. The association between gingival crevicular fluid TGF-beta1 levels and periodontal status in HIV-1 (+) patients. J Periodontol 2008;79:123-130.
20. Alves M, Mulligan R, Passaro D, et al. Longitudinal evaluation of loss of attachment in HIV-infected women compared to HIV-uninfected women. J Periodontol 2006;77:773-779.
21. Amarasena N, Ekanayaka AN, Herath L, Miyazaki H. Tobacco use and oral hygiene as risk indicators for periodontitis. Community Dent Oral Epidemiol 2002;30:115-123.
22. Axelsson P, Paulander J, Lindhe J. Relationship between smoking and dental status in 35-, 50-, 65-, and 75-year-old individuals. J Clin Periodontol 1998;25:297-305.
23. Beck JD, Slade GD. Epidemiology of periodontal diseases. Curr Opin Periodontol 1996;3:3-9.
24. Bouchard P, Boutouyrie P, Mattout C, Bourgeois D. Risk assessment for severe clinical attachment loss in an adult population. J Periodontol 2006;77:479-489.
25. Gelskey SC. Cigarette smoking and periodontitis: Methodology to assess the strength of evidence in support of a causal association. Community Dent Oral Epidemiol 1999;27:16-24.
26. Natto S, Baljoon M, Bergström J. Tobacco smoking and periodontal health in a Saudi Arabian population. J Periodontol 2005;76:1919-1926. (Pubitemid 41748981)
27. Schenkein HA, Gunsolley JC, Koertge TE, Schenkein JG, Tew JG. Smoking and its effects on early-onset periodontitis. J Am Dent Assoc 1995;126:1107-1113.
28. Scott DA, Palmer RM, Stapleton JA. Validation of smoking status in clinical research into inflammatory periodontal disease. J Clin Periodontol 2001;28:715-722.
29. Susin C, Dalla Vecchia CF, Oppermann RV, Haugejorden O, Albandar JM. Periodontal attachment loss in an urban population of Brazilian adults: Effect of demographic, behavioral, and environmental risk indicators. J Periodontol 2004;75:1033-1041.
30. Crothers K, Griffith TA, McGinnis KA, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005;20:1142-1145.
31. Dolan SE, Kanter JR, Grinspoon S. Longitudinal analysis of bone density in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 2006;91:2938-2945.
32. Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: A report from the Women's Interagency HIV Study. Am J Public Health 2006;96:1060-1065.
33. Koshiol J, Schroeder J, Jamieson DJ, et al. Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol 2006;164:176-183. (Pubitemid 43992184)
34. Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, González-Ramírez I, Ponce-de-León S. The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1, 000 consecutive patients: A 12-year study in a referral center in Mexico. Medicine (Baltimore) 2003;82:39-50.
35. Yuan Y, L'italien G, Mukherjee J, Iloeje UH. Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort. HIV Med 2006;7:156-162.
36. Guarnelli ME, Trombelli L, Calura G. Radiographic evaluation of alveolar bone height in HIV-positive patients. Minerva Stomatol 1999;48:247-255.